ArticleThe Journal of clinical endocrinology and metabolism2024

Coexisting RET/PTC and TERT Promoter Mutation Predict Poor Prognosis but Effective RET and MEK Targeting in Thyroid Cancer.

Wei Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.